Annual CAPEX
$269.00 K
-$509.00 K-65.42%
31 December 2023
Summary:
Intra-Cellular Therapies annual capital expenditures is currently $269.00 thousand, with the most recent change of -$509.00 thousand (-65.42%) on 31 December 2023. During the last 3 years, it has risen by +$2000.00 (+0.75%). ITCI annual CAPEX is now -68.74% below its all-time high of $860.60 thousand, reached on 31 December 2015.ITCI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$696.00 K
+$643.00 K+1213.21%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly capital expenditures is currently $696.00 thousand, with the most recent change of +$643.00 thousand (+1213.21%) on 30 September 2024. Over the past year, it has increased by +$428.00 thousand (+159.70%). ITCI quarterly CAPEX is now -34.49% below its all-time high of $1.06 million, reached on 30 June 2019.ITCI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$750.00 K
+$428.00 K+132.92%
30 September 2024
Summary:
Intra-Cellular Therapies TTM capital expenditures is currently $750.00 thousand, with the most recent change of +$428.00 thousand (+132.92%) on 30 September 2024. Over the past year, it has increased by +$510.00 thousand (+212.50%). ITCI TTM CAPEX is now -46.79% below its all-time high of $1.41 million, reached on 30 September 2019.ITCI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.4% | +159.7% | +212.5% |
| 3 y3 years | +0.8% | +125.2% | +88.0% |
| 5 y5 years | -31.3% | +214.8% | -46.8% |
ITCI CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.4% | +0.8% | at high | +2585.7% | -24.9% | +212.5% |
| 5 y | 5 years | -65.4% | +0.8% | at high | +207.0% | -46.8% | +263.6% |
| alltime | all time | -68.7% | +2179.7% | -34.5% | +207.0% | -46.8% | +263.6% |
Intra-Cellular Therapies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $696.00 K(+1213.2%) | $750.00 K(+132.9%) |
| June 2024 | - | $53.00 K(+5200.0%) | $322.00 K(+19.7%) |
| Dec 2023 | $269.00 K(-65.4%) | $1000.00(-99.6%) | $269.00 K(+12.1%) |
| Sept 2023 | - | $268.00 K(-1057.1%) | $240.00 K(-69.2%) |
| Dec 2022 | $778.00 K(+139.4%) | -$28.00 K(-123.9%) | $778.00 K(-3.6%) |
| Sept 2022 | - | $117.00 K(-4.9%) | $807.00 K(-19.2%) |
| June 2022 | - | $123.00 K(-78.3%) | $999.00 K(+12.1%) |
| Mar 2022 | - | $566.00 K(>+9900.0%) | $891.00 K(+174.2%) |
| Dec 2021 | $325.00 K(+21.7%) | $1000.00(-99.7%) | $325.00 K(-18.5%) |
| Sept 2021 | - | $309.00 K(+1960.0%) | $399.00 K(+53.5%) |
| June 2021 | - | $15.00 K(-80.0%) | $259.90 K(-2.6%) |
| Dec 2020 | $267.00 K(-61.9%) | $75.00 K(-55.9%) | $266.90 K(-158.2%) |
| Sept 2020 | - | $169.90 K(>+9900.0%) | -$458.40 K(+12.6%) |
| June 2020 | - | $0.00(-100.0%) | -$407.20 K(-162.1%) |
| Mar 2020 | - | $22.00 K(-103.4%) | $655.20 K(-6.5%) |
| Dec 2019 | $700.40 K(+79.0%) | -$650.30 K(-394.1%) | $700.40 K(-50.3%) |
| Sept 2019 | - | $221.10 K(-79.2%) | $1.41 M(+17.0%) |
| June 2019 | - | $1.06 M(+1481.0%) | $1.20 M(+637.1%) |
| Mar 2019 | - | $67.20 K(+14.3%) | $163.40 K(-58.2%) |
| Dec 2018 | $391.30 K | $58.80 K(+267.5%) | $391.30 K(-53.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $16.00 K(-25.2%) | $848.70 K(-9.4%) |
| June 2018 | - | $21.40 K(-92.7%) | $936.90 K(-5.4%) |
| Mar 2018 | - | $295.10 K(-42.8%) | $990.10 K(+36.8%) |
| Dec 2017 | $723.40 K(+1376.3%) | $516.20 K(+395.4%) | $723.50 K(+249.0%) |
| Sept 2017 | - | $104.20 K(+39.7%) | $207.30 K(+84.8%) |
| June 2017 | - | $74.60 K(+161.8%) | $112.20 K(+52.4%) |
| Mar 2017 | - | $28.50 K(>+9900.0%) | $73.60 K(+50.2%) |
| Dec 2016 | $49.00 K(-94.3%) | $0.00(-100.0%) | $49.00 K(-43.0%) |
| Sept 2016 | - | $9100.00(-74.7%) | $86.00 K(-53.7%) |
| June 2016 | - | $36.00 K(+823.1%) | $185.80 K(-46.0%) |
| Mar 2016 | - | $3900.00(-89.5%) | $344.10 K(-60.0%) |
| Dec 2015 | $860.60 K(+7193.2%) | $37.00 K(-66.0%) | $860.60 K(+4.1%) |
| Sept 2015 | - | $108.90 K(-44.0%) | $827.00 K(+15.2%) |
| June 2015 | - | $194.30 K(-62.7%) | $718.10 K(+35.7%) |
| Mar 2015 | - | $520.40 K(>+9900.0%) | $529.00 K(+4421.4%) |
| Dec 2014 | $11.80 K(-64.6%) | $3400.00(>+9900.0%) | $11.70 K(+41.0%) |
| Sept 2014 | - | $0.00(-100.0%) | $8300.00(0.0%) |
| June 2014 | - | $5200.00(+67.7%) | $8300.00(+167.7%) |
| Mar 2014 | - | $3100.00 | $3100.00 |
| Dec 2013 | $33.30 K(-14.6%) | - | - |
| Dec 2012 | $39.00 K | - | - |
FAQ
- What is Intra-Cellular Therapies annual capital expenditures?
- What is the all time high annual CAPEX for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual CAPEX year-on-year change?
- What is Intra-Cellular Therapies quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly CAPEX year-on-year change?
- What is Intra-Cellular Therapies TTM capital expenditures?
- What is the all time high TTM CAPEX for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM CAPEX year-on-year change?
What is Intra-Cellular Therapies annual capital expenditures?
The current annual CAPEX of ITCI is $269.00 K
What is the all time high annual CAPEX for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual capital expenditures is $860.60 K
What is Intra-Cellular Therapies annual CAPEX year-on-year change?
Over the past year, ITCI annual capital expenditures has changed by -$509.00 K (-65.42%)
What is Intra-Cellular Therapies quarterly capital expenditures?
The current quarterly CAPEX of ITCI is $696.00 K
What is the all time high quarterly CAPEX for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly capital expenditures is $1.06 M
What is Intra-Cellular Therapies quarterly CAPEX year-on-year change?
Over the past year, ITCI quarterly capital expenditures has changed by +$428.00 K (+159.70%)
What is Intra-Cellular Therapies TTM capital expenditures?
The current TTM CAPEX of ITCI is $750.00 K
What is the all time high TTM CAPEX for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM capital expenditures is $1.41 M
What is Intra-Cellular Therapies TTM CAPEX year-on-year change?
Over the past year, ITCI TTM capital expenditures has changed by +$510.00 K (+212.50%)